Stay updated with breaking news from Comparative Effectiveness. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New Phase II data show evobrutinib sustained low annualized relapse rates (ARRs) and had no new safety signals at 2.5 years the longest follow-up of any Bruton's tyrosine kinase inhibitor in multiple
Childhood trauma does not hinder progress in patients treated for bipolar disorder (BD) according to a recent published study.
Low-dose dutasteride, other oral agents top the ranking in efficacy in a meta-analysis; however, side effects need consideration, experts note.
One of the more depressing things about getting much more interested in the debate over how we should screen for common cancers, particularly breast and prostate cancer, is my increasing realization of just how little physicians themselves understand about the complexities involved in weighing the value of such tests. It's become increasingly apparent to me that most physicians believe that early detection is always good and that it always saves lives, having little or no conception of lead time or length bias.
In the United States, maternal mortality rates remain higher than in comparable countries, and racial disparities persist. While many countries have